As of 2025-10-18, the Relative Valuation of Collegium Pharmaceutical Inc (COLL) is 43.51 USD. This relative valuation is based on P/E multiples. With the latest stock price at 33.94 USD, the upside of Collegium Pharmaceutical Inc based on Relative Valuation is 28.2%.
The range of the Relative Valuation is 22.94 - 67.21 USD.
| Range | Selected | |
| Trailing P/E multiples | 19.9x - 21.8x | 20.8x |
| Forward P/E multiples | 20.7x - 24.1x | 22.6x |
| Fair Price | 22.94 - 67.21 | 43.51 |
| Upside | -32.4% - 98.0% | 28.2% |
| Date | P/E |
| 2025-10-17 | 29.48 |
| 2025-10-16 | 28.84 |
| 2025-10-15 | 28.56 |
| 2025-10-14 | 27.94 |
| 2025-10-13 | 27.83 |
| 2025-10-10 | 27.83 |
| 2025-10-09 | 28.84 |
| 2025-10-08 | 28.77 |
| 2025-10-07 | 29.00 |
| 2025-10-06 | 29.38 |
| 2025-10-03 | 30.06 |
| 2025-10-02 | 29.77 |
| 2025-10-01 | 30.54 |
| 2025-09-30 | 30.39 |
| 2025-09-29 | 30.02 |
| 2025-09-26 | 29.88 |
| 2025-09-25 | 30.09 |
| 2025-09-24 | 30.54 |
| 2025-09-23 | 30.31 |
| 2025-09-22 | 30.95 |
| 2025-09-19 | 31.05 |
| 2025-09-18 | 31.40 |
| 2025-09-17 | 30.87 |
| 2025-09-16 | 30.93 |
| 2025-09-15 | 30.33 |
| 2025-09-12 | 32.41 |
| 2025-09-11 | 33.92 |
| 2025-09-10 | 32.75 |
| 2025-09-09 | 32.98 |
| 2025-09-08 | 32.78 |
| 2025-09-05 | 33.28 |
| 2025-09-04 | 34.07 |
| 2025-09-03 | 34.38 |
| 2025-09-02 | 34.01 |
| 2025-08-29 | 33.70 |
| 2025-08-28 | 33.31 |
| 2025-08-27 | 33.69 |
| 2025-08-26 | 33.51 |
| 2025-08-25 | 33.67 |
| 2025-08-22 | 33.97 |
| 2025-08-21 | 34.32 |
| 2025-08-20 | 33.32 |
| 2025-08-19 | 32.68 |
| 2025-08-18 | 33.17 |
| 2025-08-15 | 32.78 |
| 2025-08-14 | 32.27 |
| 2025-08-13 | 32.88 |
| 2025-08-12 | 32.89 |
| 2025-08-11 | 31.39 |
| 2025-08-08 | 30.34 |